Migration and psychotic disorders

被引:24
|
作者
Veling, Wim [3 ]
Susser, Ezra [1 ,2 ]
机构
[1] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA
[2] New York State Psychiat Inst & Hosp, New York, NY 10032 USA
[3] Parnassia Psychiat Inst, Ctr Early Psychosis, The Hague, Netherlands
关键词
ethnic minorities; immigrants; incidence; psychotic disorders; social context; DUTCH ANTILLEAN IMMIGRANTS; DIFFERENT ETHNIC-GROUPS; WEST-INDIAN IMMIGRANTS; RISK-FACTOR; VITAMIN-D; 1ST-CONTACT INCIDENCE; RACIAL-DIFFERENCES; MENTAL-DISORDER; SOCIAL DEFEAT; 1ST CONTACT;
D O I
10.1586/ERN.10.91
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The incidence of psychotic disorders is extremely high in several immigrant groups in Europe. This article describes the epidemiological evidence for increased incidence rates among immigrants compared with nonimmigrant populations and explores possible explanations for this excess risk. Potential causes not only involve factors acting at the level of the individual, but encompass the broader social context of neighborhoods and ethnic groups. Growing up and living in a disadvantaged ethnic minority position, characterized by a low social status, high degree of discrimination against the group and low neighborhood ethnic density, may lead to an increased risk of psychotic disorders, especially when individuals reject their minority status and when their social resources are insufficient to buffer the impact of adverse social experiences. Future research should refine measures of the social context, adopt a life-course perspective and should integrate social and neurobiological pathways.
引用
收藏
页码:65 / 76
页数:12
相关论文
共 50 条
  • [41] Immunologic Therapeutics and Psychotic Disorders
    Bullmore, Edward T.
    Lynall, Mary-Ellen
    BIOLOGICAL PSYCHIATRY, 2014, 75 (04) : 260 - 261
  • [42] Future classification of psychotic disorders
    Wolfgang Gaebel
    Jürgen Zielasek
    European Archives of Psychiatry and Clinical Neuroscience, 2009, 259 : 213 - 218
  • [43] Twin studies in psychotic disorders
    Bellani, Marcella
    Fagnani, Corrado
    Brambilla, Paolo
    EPIDEMIOLOGIA E PSICHIATRIA SOCIALE-AN INTERNATIONAL JOURNAL FOR EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES, 2009, 18 (03): : 195 - 199
  • [44] CSF GABA IN PSYCHOTIC DISORDERS
    BOWERS, MB
    GOLD, BI
    ROTH, RH
    PSYCHOPHARMACOLOGY, 1980, 70 (03) : 279 - 282
  • [45] New treatments for psychotic disorders
    Nieman, Dorien H.
    LANCET PSYCHIATRY, 2015, 2 (04): : 282 - 283
  • [46] Pregnancy in women with psychotic disorders
    Barkla J.
    Byrne L.
    Hearle J.
    Plant K.
    Jenner L.
    McGrath J.
    Archives of Women's Mental Health, 2000, 3 (1) : 23 - 26
  • [47] Estradiol levels in psychotic disorders
    Huber, TJ
    Rollnik, J
    Wilhelms, J
    von zur Mühlen, A
    Emrich, HM
    Schneider, U
    PSYCHONEUROENDOCRINOLOGY, 2001, 26 (01) : 27 - 35
  • [48] ADHD Medications and Psychotic Disorders
    Duran Alvarez, H.
    Macias Saint-Gerons, D.
    Giraldo, G.
    Castro, J.
    Tabares-Seisdedos, R.
    DRUG SAFETY, 2019, 42 (10) : 1271 - 1272
  • [49] In search of biomarkers for psychotic disorders
    Bahn, S
    JOURNAL OF NEUROCHEMISTRY, 2005, 94 : 156 - 156
  • [50] rTMS for the treatment of psychotic disorders
    Langguth, B
    Hajak, G
    Eichhammer, P
    PROCEEDINGS OF THE MENTAL DYSFUNCTIONS IN PARKINSON'S DISEASE, 2004, : 39 - 44